Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials

Major, Pierre; Lortholary, Alain; K. Hon, Jeremy; Abdi, Ehtesham; Mills, Glenn; D. Menssen, H.; Yunus, F.; Bell, R.; Body, J.J.; Quebe‐Fehling, Erhard; J. Seaman, John

doi:10.1200/jco.2001.19.2.558

Public

Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials

Published in Journal of Clinical Oncology • Jan 15, 2001

Authors:

Pierre Major

Alain Lortholary

Jeremy K. Hon

Abstract

PURPOSE: Two identical, concurrent, parallel, multicenter, randomized, double-blind, double-dummy trials were conducted to compare the efficacy and safety of zoledronic acid and pamidronate for treating hypercalcemia of malignancy (HCM). PATIENTS AND METHODS: Patients with moderate to severe HCM (co...

Subject

Zoledronic acid

Medicine

Bisphosphonate

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!